LOW INCIDENCE AND MINIMAL IMPACT OF PARAVALVULAR LEAK AFTER CONVENTIONAL AORTIC VALVE REPLACEMENT.

mohamed elghanam, Mohamed Zeinah

Abstract


OBJECTIVES: To evaluate the incidence of paravalvular leaks (PVLs) after surgical aortic valve replacement (AVR) and assess its impact on postoperative outcomes.

METHODS: A retrospective review of 460 consecutive isolated AVR from January 2008 to December 2014. Postoperative transthoracic echocardiograms (TTE) and clinical notes were reviewed.

RESULTS: Thirty-five patients (7.6%) developed a PVL and formed the cohort of this report. TTE grading of PVL was trivial in 18 (51.4%), mild in 14 (40%), moderate in 2 (5.7%) and severe in 1 patient (2.9%), with an overall prevalence of developing moderate to severe PVL after AVR of 0.065%. Mean age was 63 years, 23 patients were males (65.7%) and mean logistic Euroscore was 8.35 + 15.8%. Valve lesions were mainly stenosis (24 patients; 68.6%), regurgitation (7 patients; 20%) and mixed aortic lesions (4 patients; 11.4%). Implanted prostheses were 19 bioprosthesis  (54.2%) and 16 mechanical valves  (45.8%). We had one 30-days mortality (2.8%), 13 postoperative new onset atrial fibrillation (37%), permanent pacemaker 2.8%, cerebrovascular stroke 2.8%, re sternotomy for bleeding 2.8% and two patients needed hemodialysis (5.7%). Patients were followed up for 0.9 + 1.2 years. When last seen, 27 patients were in NYHA class I (77.1%), six patients were in class II (17.1%) and two patients with moderate to severe PVL remained in NYHA class IV (5.7%). Peak aortic valve gradients ranged from 14 to 68 mmHg, with a mean gradient of 27.8 + 13.3 mm Hg. Three patients with trivial PVL (8.5%) developed prosthetic valve endocarditis, with 2 patients among them requiring intervention for prosthetic valve failure (5.7%). Demographics, preoperative risk profiles and hospital outcomes were comparable to those recorded in the remaining 425 patients without PVL.

CONCLUSION: The incidence of PVL after conventional AVR is small and the development of moderate or greater leaks is negligible. Trivial to mild leaks had a benign course unless complicated by PVE. New percutaneous therapies for aortic valve disease must match these low rates.

Key words: Paravalvular leak, prosthetic valve dysfunction, aortic valve.


Full Text:

PDF

References


Lawrence H. Cohn. Cardiac surgery in the adult (Fourth Edition). New York: McGraw-Hill, 2011. 151.

Safi AM, Kwan T. Paravalvular regurgitation: a rare complication following valve replacement surgery. Angiology 2000; 51: 479-487.

Rallidis LS; Moyssakis IE; Ikonomidis I; Nihoyannopoulos P. Natural History of early paraprosthetic regurgitation: A five-year follow up. Am Heart J 1999; 138(2): 351-357.

Nair S, Bhatnagar G, Valencia O, Chandrasekaran V: Effect of valve suture technique on incidence of paraprosthetic regurgitation and 10-Year survival. Ann Thorac Surg 2010, 89:1171-1179.

O-Rourke DJ, Palac RT. Outcome of mild periprostetic regurgitation detected by intraoperative transesophadeal echocardiography. J Am Coll Cardiol 2001; 38: 163-166.

Pate GE, Al Zubaidi A. Percutaneous closure of prosthetic paravalvular leaks: case series and review. Catheter Cardiovasc Interv 2006;68: 528-533

Lund O, Emmertsen K, Nielsen T, Jensen F, Christian F, Pilegaard H, Rasmussen B, et al.

Impact of Size Mismatch and Left Ventricular Function on Performance of the St. Jude Disc Valve After Aortic Valve Replacement. Ann. Thorac. Surg 1997; 63: 1227-1234.

Genoni M, Franzen D, Vogt P, Seifert B, Jenni R, Künzli A, et al. Paravalvular leakage after mitral valve replacement: improved long-term survival with aggressive surgery? Eur J Cardiothorac Surg. 2000;17(1): 14-19.

Murtuza B, Pepper J, Stanbridge R, Jones C, Rao C, Darzi A, et al. Minimal Access Aortic Valve Replacement: Is It Worth It? Ann Thorac Surg 2008;85:1121-1131.

Umakanthan R, Petracek MR, Leacche M, Solenkova NV, Eagle SS, Thompson A, et al. Minimally invasive right lateral thoracotomy without aortic cross-clamping: an attractive alternative to repeat sternotomy for reoperative mitral valve surgery. J Heart Valve Dis. 2010;19(2):236-243.

Chu M, Borger M, Mohr F, Walther T. Transcatheter heart-valve replacement: update. CMAJ. 2010; 182(8): 791–795.

Akins CW, Bitondo JM, Hilgenberg AD, Vlahakes GJ, Madsen JC, MacGillivray TE. Early and late results of the surgical correction of cardiac prosthetic paravalvular leaks. J Heart Valve Dis 2005;14(6):792–799.

Ionescu A, Fraser AG, Butchart EG. Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesophageal echocardiography. Heart 2003, 89:1316-1321.

Davila-Roman VG and Waggoner AD. Prevalence and severity of paravalvular regurgitation in the Artificial Valve Endocarditis Reduction Trial (AVERT) echocardiographic study. J Am Coll Cardiol 2004; 44: 1467-1472.

Schaff H, Carrel T, Jamieson W, Jones k, Rufilanchas J, Cooley D, et al. Paravalvular leak and other events in silzone-coated mechanical heart valves: a report from AVERT. Ann Thorac Surg 2002; 73:785.

De Cicco G, Lorusso R, Colli A, Nicolini F, Fragnito C, Grimaldi T, et al. Aortic valve periprosthetic leakage, anatomic observations and surgical results. Ann Thorac Surg 2005; 79:1480.

Mack M, Leon M, Smith C, Miller D, Moses J, Tuzcu E, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. The Lancet 2015; 385, 9986: 2477–2484.

Watanabe Y, Lefèvre T, Arai T, Hayashida K, Bouvier E, Hovasse T, et al. Can we predict postprocedural paravalvular leak after Edwards SAPIEN transcatheter aortic valve implantation? Catheter cardiovasc interv 2015 Jul;86(1):144-51.

Shrestha M, Folliguet T, Meuris B, Dibie A, Bara C, Herregods MC, et al. Sutureless Perceval S aortic valve replacement: a multicenter, prospective pilot trial. J Heart Valve Dis 2009;18 (6):698-702.

Sepehripour AH, Harling L, Athanasiou T. What are the current results of sutureless valves in high-risk aortic valve disease patients? Interact Cardiovasc Thorac Surg 2012; 14 (5):615-621.


Refbacks

  • There are currently no refbacks.




Copyright (c) 2016 Mohamed Elghanam, Mohamed Zeinah

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.